Up-Regulation of LINC00665 Facilitates the Malignant Progression of Prostate Cancer by Epigenetically Silencing KLF2 Through EZH2 and LSD1
This study aimed to explore the function of LINC00665 on the proliferation and metastasis of prostate cancer (PCa), and the potential regulatory mechanisms were also investigated. The expression level of LINC00665 in 50 pairs of PCa tissues and adjacent ones was studied by qRT-PCR, and the associati...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-05-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.639060/full |
_version_ | 1818458074192543744 |
---|---|
author | Peng Xue Miao Yan Kunpeng Wang Jinbao Gu Bing Zhong Chuanquan Tu |
author_facet | Peng Xue Miao Yan Kunpeng Wang Jinbao Gu Bing Zhong Chuanquan Tu |
author_sort | Peng Xue |
collection | DOAJ |
description | This study aimed to explore the function of LINC00665 on the proliferation and metastasis of prostate cancer (PCa), and the potential regulatory mechanisms were also investigated. The expression level of LINC00665 in 50 pairs of PCa tissues and adjacent ones was studied by qRT-PCR, and the associations between LINC00665 and clinicopathological characteristics of PCa patients were analyzed. Control group (sh-NC) and LINC00665 knock-down group (sh-LINC00665) were set in 22RV1 and DU145 cells, respectively. The biological functions of LINC00665 in PCa cell lines were assessed by CCK-8, EdU, Transwell assays, and the nude mouse xenograft model was used to evaluate the tumorigenicity in vivo. In addition, qRT-PCR, Western Blot, RIP and ChIP assays were also used to determine the regulation mechanism of LINC00665 in PCa cell lines. In this study, our results showed that LINC00665 expression level in PCa cancer tissues was significantly up-regulated, compared with that in adjacent ones. Besides, similar results were found in PCa cell lines. Knock-down of LINC00665 significantly attenuated the proliferation and migration ability in 22RV1 and DU145 cells, compared to sh-NC. Mechanically, LINC00665 could interact with EZH2 and LSD1, recruiting them to KLF2 promoter region to inhibit its transcription. Moreover, the tumor-suppressive effects mediated by sh-LINC00665 were significantly reversed through the down-regulation of KLF2. Also, the suppression of LINC00665 impaired tumor growth of PCa in vivo. In summary, LINC00665 exerted the oncogenic functions in PCa cell lines by epigenetically silencing KLF2 expression by binding to EZH2 and LSD1, illuminating a novel mechanism of LINC00665 in the malignant progression of PCa and furnishing a prospective therapeutic biomarker to combat PCa. |
first_indexed | 2024-12-14T22:52:40Z |
format | Article |
id | doaj.art-6dbb3821bc0f4bd2b4da22d0ee092bd9 |
institution | Directory Open Access Journal |
issn | 2234-943X |
language | English |
last_indexed | 2024-12-14T22:52:40Z |
publishDate | 2021-05-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Oncology |
spelling | doaj.art-6dbb3821bc0f4bd2b4da22d0ee092bd92022-12-21T22:44:40ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2021-05-011110.3389/fonc.2021.639060639060Up-Regulation of LINC00665 Facilitates the Malignant Progression of Prostate Cancer by Epigenetically Silencing KLF2 Through EZH2 and LSD1Peng Xue0Miao Yan1Kunpeng Wang2Jinbao Gu3Bing Zhong4Chuanquan Tu5Department of Urology, The First People’s Hospital of Lianyungang, Lianyungang Clinical Medical College of Nanjing Medical University, Lianyungang, ChinaDepartment of Oncology, The First People’s Hospital of Lianyungang, Lianyungang Clinical Medical College of Nanjing Medical University, Lianyungang, ChinaDepartment of Urology, The First People’s Hospital of Lianyungang, Lianyungang Clinical Medical College of Nanjing Medical University, Lianyungang, ChinaDepartment of Urology, The First People’s Hospital of Lianyungang, Lianyungang Clinical Medical College of Nanjing Medical University, Lianyungang, ChinaDepartment of Urology, The Affiliated Huai’an No.1 People’s Hospital of Nanjing Medical University, Huai’an, ChinaDepartment of Urology, The First People’s Hospital of Lianyungang, Lianyungang Clinical Medical College of Nanjing Medical University, Lianyungang, ChinaThis study aimed to explore the function of LINC00665 on the proliferation and metastasis of prostate cancer (PCa), and the potential regulatory mechanisms were also investigated. The expression level of LINC00665 in 50 pairs of PCa tissues and adjacent ones was studied by qRT-PCR, and the associations between LINC00665 and clinicopathological characteristics of PCa patients were analyzed. Control group (sh-NC) and LINC00665 knock-down group (sh-LINC00665) were set in 22RV1 and DU145 cells, respectively. The biological functions of LINC00665 in PCa cell lines were assessed by CCK-8, EdU, Transwell assays, and the nude mouse xenograft model was used to evaluate the tumorigenicity in vivo. In addition, qRT-PCR, Western Blot, RIP and ChIP assays were also used to determine the regulation mechanism of LINC00665 in PCa cell lines. In this study, our results showed that LINC00665 expression level in PCa cancer tissues was significantly up-regulated, compared with that in adjacent ones. Besides, similar results were found in PCa cell lines. Knock-down of LINC00665 significantly attenuated the proliferation and migration ability in 22RV1 and DU145 cells, compared to sh-NC. Mechanically, LINC00665 could interact with EZH2 and LSD1, recruiting them to KLF2 promoter region to inhibit its transcription. Moreover, the tumor-suppressive effects mediated by sh-LINC00665 were significantly reversed through the down-regulation of KLF2. Also, the suppression of LINC00665 impaired tumor growth of PCa in vivo. In summary, LINC00665 exerted the oncogenic functions in PCa cell lines by epigenetically silencing KLF2 expression by binding to EZH2 and LSD1, illuminating a novel mechanism of LINC00665 in the malignant progression of PCa and furnishing a prospective therapeutic biomarker to combat PCa.https://www.frontiersin.org/articles/10.3389/fonc.2021.639060/fullLINC00665malignant progressionprostate cancerKLF2EZH2LSD1 |
spellingShingle | Peng Xue Miao Yan Kunpeng Wang Jinbao Gu Bing Zhong Chuanquan Tu Up-Regulation of LINC00665 Facilitates the Malignant Progression of Prostate Cancer by Epigenetically Silencing KLF2 Through EZH2 and LSD1 Frontiers in Oncology LINC00665 malignant progression prostate cancer KLF2 EZH2 LSD1 |
title | Up-Regulation of LINC00665 Facilitates the Malignant Progression of Prostate Cancer by Epigenetically Silencing KLF2 Through EZH2 and LSD1 |
title_full | Up-Regulation of LINC00665 Facilitates the Malignant Progression of Prostate Cancer by Epigenetically Silencing KLF2 Through EZH2 and LSD1 |
title_fullStr | Up-Regulation of LINC00665 Facilitates the Malignant Progression of Prostate Cancer by Epigenetically Silencing KLF2 Through EZH2 and LSD1 |
title_full_unstemmed | Up-Regulation of LINC00665 Facilitates the Malignant Progression of Prostate Cancer by Epigenetically Silencing KLF2 Through EZH2 and LSD1 |
title_short | Up-Regulation of LINC00665 Facilitates the Malignant Progression of Prostate Cancer by Epigenetically Silencing KLF2 Through EZH2 and LSD1 |
title_sort | up regulation of linc00665 facilitates the malignant progression of prostate cancer by epigenetically silencing klf2 through ezh2 and lsd1 |
topic | LINC00665 malignant progression prostate cancer KLF2 EZH2 LSD1 |
url | https://www.frontiersin.org/articles/10.3389/fonc.2021.639060/full |
work_keys_str_mv | AT pengxue upregulationoflinc00665facilitatesthemalignantprogressionofprostatecancerbyepigeneticallysilencingklf2throughezh2andlsd1 AT miaoyan upregulationoflinc00665facilitatesthemalignantprogressionofprostatecancerbyepigeneticallysilencingklf2throughezh2andlsd1 AT kunpengwang upregulationoflinc00665facilitatesthemalignantprogressionofprostatecancerbyepigeneticallysilencingklf2throughezh2andlsd1 AT jinbaogu upregulationoflinc00665facilitatesthemalignantprogressionofprostatecancerbyepigeneticallysilencingklf2throughezh2andlsd1 AT bingzhong upregulationoflinc00665facilitatesthemalignantprogressionofprostatecancerbyepigeneticallysilencingklf2throughezh2andlsd1 AT chuanquantu upregulationoflinc00665facilitatesthemalignantprogressionofprostatecancerbyepigeneticallysilencingklf2throughezh2andlsd1 |